3rd Annual Biomarker Conference
Event Feb 08 - Feb 09, 2018
Location: San Diego, CA, USA
With growing pressures of increasing success rates for FDA approved biomarkers as well as companion diagnostics tests has seen an outgrowth in drug discovery companies to invest in novel strategies for biomarker discovery.
The major challenges faced in securing these approvals include identifying clinical relevance in the context of therapeutic targets and novel technologies to measure disease activity, reproducibility, variability issues- and finally translation of discoveries to FDA approved clinical tests.